AI stethoscope doubles detection of serious valve disease in primary care study

By Admin

09 Feb, 2026

Introduction
Early detection of valvular heart disease (VHD) remains one of the biggest challenges in primary care. A recent prospective study published in the European Heart Journal Digital Health highlights how an artificial intelligence (AI)–enabled digital stethoscope can significantly improve detection rates of serious valve disease compared to traditional auscultation, potentially reshaping frontline cardiac screening.

Understanding Valvular Heart Disease
Valvular heart disease occurs when one or more heart valves   aortic, mitral, tricuspid, or pulmonary   fail to open or close properly, disrupting normal blood flow. Common symptoms include shortness of breath, fatigue, chest pain, and palpitations. However, diagnosis is often delayed because more than half of patients with clinically significant disease are asymptomatic. Prevalence increases sharply with age, affecting over half of adults above 65 to some extent, making effective screening in primary care crucial.

Why Traditional Auscultation Falls Short
Clinician-performed auscultation using standard stethoscopes has long been the first step in detecting VHD. Yet previous research shows that even experienced general practitioners demonstrate limited sensitivity, particularly when screening asymptomatic patients. This limitation contributes to missed or late diagnoses, allowing disease progression before specialist referral.

Study Design and Methodology
This prospective single-arm diagnostic accuracy study was conducted across three primary care clinics between June 2021 and May 2023. It included 357 patients aged 50 years and older who were at elevated cardiovascular risk but had no known history of VHD or cardiac murmurs.

Risk factors included hypertension, obesity (BMI ≥30), diabetes, hyperlipidaemia, atrial fibrillation, prior myocardial infarction, stroke or transient ischemic attack, coronary revascularisation, and other established cardiovascular conditions.

Participants underwent two parallel screening approaches. In standard-of-care screening, primary care providers performed four-point cardiac auscultation using conventional stethoscopes. In AI-augmented screening, phonocardiogram recordings were captured using a digital stethoscope and analysed by an FDA-cleared AI algorithm designed to detect heart murmurs. All patients then underwent echocardiography, with an independent expert panel reviewing digital audio recordings while blinded to AI results.

Key Findings and Diagnostic Performance
The AI-enabled system demonstrated markedly superior sensitivity in detecting audible moderate-to-severe VHD. Sensitivity reached 92.3 percent with AI-assisted screening, compared to just 46.2 percent using standard care. Among confirmed cases, clinicians missed seven out of thirteen patients, while the AI system missed only one.

Notably, the AI tool identified twice as many previously undiagnosed moderate-to-severe cases   twelve compared to six detected by primary care providers. Even when echocardiography alone was used as the reference standard, regardless of murmur audibility, AI screening maintained higher sensitivity than traditional examination.

This improved detection came with a trade-off. Specificity was lower for the AI system at 86.9 percent versus 95.6 percent for clinicians, resulting in more false-positive findings and potentially increased echocardiography referrals.

Clinical Implications for Primary Care
The findings suggest that AI-enabled digital stethoscopes can serve as a powerful screening adjunct in primary care rather than a replacement for clinical judgement. By acting as a second layer of support, these tools may help clinicians identify high-risk patients earlier and refer them for confirmatory imaging before symptoms develop.

However, increased sensitivity alone does not guarantee better patient outcomes. The study focused on diagnostic accuracy and did not evaluate long-term management, prognosis, or cost-effectiveness. Higher false-positive rates may also increase healthcare utilisation, underscoring the need for balanced implementation strategies.

Limitations and Considerations
The study had several limitations, including a modest sample size, limited geographic scope, incomplete demographic data, and lack of systematic symptom assessment. Additionally, some authors disclosed affiliations with the device manufacturer, which should be considered when interpreting results despite transparency around conflicts of interest.

Conclusion
This study provides compelling evidence that AI-augmented digital stethoscopes can significantly enhance the detection of serious valvular heart disease in primary care settings. While not a substitute for clinical expertise, these tools may represent a meaningful advancement in point-of-care cardiac screening, enabling earlier identification and potentially improving referral pathways for patients at risk.